The DOI matches its Crossref record.
Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens
Abstract
Nitrofurantoin is an effective urinary tract antibacterial to which no clinically significant resistance development has occurred. We have previously shown that nitrofurantoin susceptibility in bacteria correlates with the presence of bacterial nitroreductases which convert nitrofurantoin to highly reactive electrophilic intermediates. These intermediates were shown to attack bacterial ribosomal proteins non-specifically, causing complete inhibition of protein synthesis. In the present study, we confirm previous reports that low concentrations of nitrofurantoin specifically inhibit inducible enzyme synthesis in bacteria, and show that this inhibition occurs at levels equivalent to the MICs of nitrofurantoin for several bacterial species. Our previous studies had shown that nitrofurantoin at different concentrations interacts with bacterial ribosomal proteins in qualitatively the same fashion; we now report that quantitative differences are seen in the labelling observed at different nitrofurantoin concentrations and discuss these differences as they may relate to the inhibition of inducible enzyme synthesis. In addition, we have now demonstrated the existence of a novel mechanism of action for nitrofurantoin which does not require the production of reactive nitrofurantoin metabolites by bacterial reductases. The lack of clinically significant bacterial resistance development to nitrofurantoin is likely due to the combination of nitrofurantoin's multiple sites of attack and multiple mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Phenotypic Landscape of a Bacterial Cell
Nichols, R. J., Sen, S., Choo, Y. J., Beltrao, P., Zietek, M., Chaba, R., Lee, S., Kazmierczak, K. M., Lee, K. J., Wong, A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.052 · Cited by 713
Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., & Sahm, D. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2540-2545.2002 · Cited by 367
Emergence and management of drug-resistant enterococcal infections
Arias, C. A., & Murray, B. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.637 · Cited by 294
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
Huttner, A., Verhaegh, E. M., Harbarth, S., Muller, A. E., Theuretzbacher, U., & Mouton, J. W. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv147 · Cited by 267
Origins of the Quinolone Class of Antibacterials: An Expanded “Discovery Story”: Miniperspective
Bisacchi, G. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501881c · Cited by 252
Hussein, M., Sun, Z., Hawkey, J., Allobawi, R., Judd, L. M., Carbone, V., Sharma, R., Thombare, V., Baker, M., Rao, G. G., et al. (2024) · mSystems · doi:10.1128/msystems.00972-23 · Cited by 14
“The observed perturbations of aminoacyl-tRNA biosynthesis and purine metabolism are in line with the primary mode of bacterial killing instigated by the unstable nitrofur antoin metabolites, which involves disruption of bacterial DNA, RNA, and protein synthesis (14, 41–43).”
BackgroundSteenhuis, M., Koningstein, G. M., Oswald, J., Pick, T., O’Keefe, S., Koch, H., Cavalié, A., Whitehead, R. C., Swanton, E., High, S., et al. (2021) · Molecular Microbiology · doi:10.1111/mmi.14589 · Cited by 11
Metadata
- Authors
- McOsker, C. C., & Fitzpatrick, P. M.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-05-01
- Volume
- 33
- Issue
- suppl A
- Pages
- 23-30
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2088906839
- Cited by
- 268
- References
- 0
- FWCI
- 0.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.